Cargando…
Infections and diabetes: Risks and mitigation with reference to India
BACKGROUND AND AIMS: The link between diabetes and increased risk of infectious disease has long been recognized, but has re-entered sharp focus following the COVID-19 pandemic. METHODS: A literature search was conducted in PubMed for articles in English on diabetes and infection. RESULTS: Diabetes...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Diabetes India. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505871/ https://www.ncbi.nlm.nih.gov/pubmed/33002780 http://dx.doi.org/10.1016/j.dsx.2020.09.022 |
_version_ | 1783584905178906624 |
---|---|
author | Unnikrishnan, Ranjit Misra, Anoop |
author_facet | Unnikrishnan, Ranjit Misra, Anoop |
author_sort | Unnikrishnan, Ranjit |
collection | PubMed |
description | BACKGROUND AND AIMS: The link between diabetes and increased risk of infectious disease has long been recognized, but has re-entered sharp focus following the COVID-19 pandemic. METHODS: A literature search was conducted in PubMed for articles in English on diabetes and infection. RESULTS: Diabetes predisposes to infections through alterations in innate and acquired immune defenses. Outcomes of infection are worse in people with uncontrolled diabetes, and infection can worsen hyperglycemia in hitherto well controlled diabetes (bidirectional relationship). Diabetes does not increase the risk of infection with COVID-19 per se, but predisposes to severe disease and poor outcomes. COVID-19 has also been linked to deterioration of glycemic control as well as new-onset diabetes. CONCLUSIONS: Clinicians caring for people with diabetes should be aware of the increased risk of infections in this population, as well as the possibility of worsening hyperglycemia. A holistic approach with frequent monitoring of blood glucose levels and appropriate titration of medications, along with close attention to nutritional status, is essential to ensure the best possible outcomes. |
format | Online Article Text |
id | pubmed-7505871 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Diabetes India. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-75058712020-09-23 Infections and diabetes: Risks and mitigation with reference to India Unnikrishnan, Ranjit Misra, Anoop Diabetes Metab Syndr Article BACKGROUND AND AIMS: The link between diabetes and increased risk of infectious disease has long been recognized, but has re-entered sharp focus following the COVID-19 pandemic. METHODS: A literature search was conducted in PubMed for articles in English on diabetes and infection. RESULTS: Diabetes predisposes to infections through alterations in innate and acquired immune defenses. Outcomes of infection are worse in people with uncontrolled diabetes, and infection can worsen hyperglycemia in hitherto well controlled diabetes (bidirectional relationship). Diabetes does not increase the risk of infection with COVID-19 per se, but predisposes to severe disease and poor outcomes. COVID-19 has also been linked to deterioration of glycemic control as well as new-onset diabetes. CONCLUSIONS: Clinicians caring for people with diabetes should be aware of the increased risk of infections in this population, as well as the possibility of worsening hyperglycemia. A holistic approach with frequent monitoring of blood glucose levels and appropriate titration of medications, along with close attention to nutritional status, is essential to ensure the best possible outcomes. Diabetes India. Published by Elsevier Ltd. 2020 2020-09-22 /pmc/articles/PMC7505871/ /pubmed/33002780 http://dx.doi.org/10.1016/j.dsx.2020.09.022 Text en © 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Unnikrishnan, Ranjit Misra, Anoop Infections and diabetes: Risks and mitigation with reference to India |
title | Infections and diabetes: Risks and mitigation with reference to India |
title_full | Infections and diabetes: Risks and mitigation with reference to India |
title_fullStr | Infections and diabetes: Risks and mitigation with reference to India |
title_full_unstemmed | Infections and diabetes: Risks and mitigation with reference to India |
title_short | Infections and diabetes: Risks and mitigation with reference to India |
title_sort | infections and diabetes: risks and mitigation with reference to india |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505871/ https://www.ncbi.nlm.nih.gov/pubmed/33002780 http://dx.doi.org/10.1016/j.dsx.2020.09.022 |
work_keys_str_mv | AT unnikrishnanranjit infectionsanddiabetesrisksandmitigationwithreferencetoindia AT misraanoop infectionsanddiabetesrisksandmitigationwithreferencetoindia |